Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Submitted by
admin
on September 3, 2013 - 11:19am
Source:
Fierce Biotech
News Tags:
Coherus Biosciences
Baxter International
Enbrel
biosimilars
Amgen
Headline:
Coherus inks $246M Baxter deal to develop Enbrel biosimilar
Do Not Allow Advertisers to Use My Personal information
